These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4305332)

  • 21. [Corticotropin releasing factor].
    Conte-Devolx B; Oliver C; Rey M; Guillaume V; Castanas E; Giraud P; Boudouresque F; Grino M
    Presse Med; 1985 Mar; 14(13):737-41. PubMed ID: 2986091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of corticosteroids on the secretion of corticotrophin and its hypothalamic releasing hormone.
    Buckingham JC
    J Physiol; 1979 Jan; 286():331-42. PubMed ID: 220413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of vasopressin and of a crude CRF preparation on pituitary ACTH-release in posterior-lobectomized rats.
    de Wied D
    Neuroendocrinology; 1968; 3(3):129-35. PubMed ID: 4301554
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional reactivation and cytological restoration of pituitary grafts by continuous local intravascular infusion of median eminence extracts.
    Evans JS; Nikitovitch-Winer MB
    Neuroendocrinology; 1969; 4(2):83-100. PubMed ID: 4305346
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of ovariectomy on pituitary secretion of ACTH.
    Coyne MD; Kitay JI
    Endocrinology; 1969 Dec; 85(6):1097-102. PubMed ID: 4310485
    [No Abstract]   [Full Text] [Related]  

  • 26. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):787-94. PubMed ID: 1847212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of effects of 6-dehydro-16-methylene-hydrocortisone (STC 407) and dexamethasone on the suppression of the hypothalamo-pituitary-adrenal system.
    Berthold K; Arimura A; Schally AV
    Acta Endocrinol (Copenh); 1970 Mar; 63(3):423-30. PubMed ID: 4317301
    [No Abstract]   [Full Text] [Related]  

  • 28. Corticotropin release: inhibition by intrahypothalamic implantation of atropine.
    Hedge GA; Smelik PG
    Science; 1968 Feb; 159(3817):891-2. PubMed ID: 4295146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy.
    Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP
    J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved parameters of pituitary incubation for the assay of corticotrophin-releasing factor.
    Seiden G; Brodish A
    Neuroendocrinology; 1971; 8(3):145-53. PubMed ID: 4328627
    [No Abstract]   [Full Text] [Related]  

  • 31. Some aspects of corticosteroid feedback actions.
    Smelik PG
    Ann N Y Acad Sci; 1977 Oct; 297():580-90. PubMed ID: 211919
    [No Abstract]   [Full Text] [Related]  

  • 32. Corticosterone implants in the paraventricular nucleus inhibit ACTH and corticosterone responses and the release of corticotropin-releasing factor following neural stimuli.
    Feldman S; Saphier D; Weidenfeld J
    Brain Res; 1992 Apr; 578(1-2):251-5. PubMed ID: 1324761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plastic fetal pituitary.
    Tortoriello DV
    J Clin Invest; 2002 Sep; 110(6):749-50. PubMed ID: 12235105
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice.
    Corrêa-de-Santana E; Paez-Pereda M; Theodoropoulou M; Kenji Nihei O; Gruebler Y; Bozza M; Arzt E; Villa-Verde DM; Renner U; Stalla J; Stalla GK; Savino W
    J Neuroimmunol; 2006 Apr; 173(1-2):12-22. PubMed ID: 16494952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal.
    Zhou Y; Spangler R; Schlussman SD; Ho A; Kreek MJ
    Brain Res; 2003 Feb; 964(2):187-99. PubMed ID: 12576179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of corticotropin-releasing factor, dexamethasone and actinomycin D on the release of ACTH from rat pituitaries in vivo and in vitro.
    Arimura A; Bowers CY; Schally AV; Saito M; Miller MC
    Endocrinology; 1969 Aug; 85(2):300-11. PubMed ID: 4306603
    [No Abstract]   [Full Text] [Related]  

  • 38. Copeptin as a marker of an altered CRH axis in pituitary disease.
    Lewandowski KC; Lewiński A; Skowrońska-Jóźwiak E; Malicka K; Horzelski W; Brabant G
    Endocrine; 2017 Sep; 57(3):474-480. PubMed ID: 28795329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats.
    Hauger RL; Thrivikraman KV; Plotsky PM
    Endocrinology; 1994 Mar; 134(3):1528-36. PubMed ID: 8119195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.